7Baggers

InnovAge Holding Corp
(NASDAQ:INNV) 

INNV stock logo

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-hom...

Founded: 2007
CEO: Maureen Hewitt  
Sector: Healthcare
Industry: Medical Care Facilities
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-10-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2011-01-01 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2010-01-01 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2009-01-01 2008-12-31 2008-09-30 2008-06-30 2008-03-31 
                                                       
      net revenue:
    		                                                   
      product sales
    		5,648,000 6,594,000 5,189,000  6,956,861 6,970,312 4,542,026 2,379,510 2,218,343 2,031,157 2,177,290 1,691,491 1,882,129 1,019,520 224,463     282,154 118,087 113,784  6,196 445 166                          
      service revenue
    		 56,000 100,000  189,462 155,648                                              
      cooperative marketing revenue
    		102,000 91,000 71,000  233,074 183,636                                              
      license revenue
    		5,000 107,000 3,000  582 2,577 2,578  2,500 7,500                                          
      net revenue
    		5,755,000 6,848,000 5,363,000  7,379,979 7,312,173 4,544,604 2,379,510 2,220,843 2,038,657 2,177,290                                         
      cost of product sales
    		2,215,000 2,356,000 1,778,000  1,536,792 1,338,950 864,095 519,194 480,076 408,579 440,476 368,810 331,227 262,934 120,123    76,420 134,384 51,299                               
      gross profit
    		3,540,000 4,492,000 3,585,000             79,315.25 77,385 119,444    63,238 110,237    279                         
      yoy
    		                 88.88%     39411.47%                             
      qoq
    		-21.19% 25.30%              2.49% -35.21%     -42.63%                              
      gross margin %
    		Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% Infinity% Infinity% Infinity% NaN% NaN% NaN% Infinity% Infinity% 0% 0% 0% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%  NaN% NaN% NaN% NaN%  NaN% NaN% NaN% NaN% 
      operating expense:
    		                                                   
      research and development
    		86,000 91,000 56,000  59,201 22,605 11,287 11,829 8,736 15,063 3,183 30,137 43,775 3,892      15,334 18,885 54,128 55,567 26,581 147,302 66,342                          
      sales and marketing
    		2,878,000 2,858,000 2,595,000  5,263,533 5,528,886 3,301,784 1,983,842 1,626,630 1,555,736 1,687,351 1,363,879 1,972,155                                       
      general and administrative
    		2,274,000 2,724,000 2,435,000  2,023,030 1,919,301 1,696,021 966,928 1,321,001 1,182,235 1,704,663 1,858,215 1,779,048 1,195,087 1,323,233 829,001 731,221 901,968 1,448,002 1,092,826 993,951 1,006,382 1,285,590 713,912 3,532,837 648,127 494,328 42,939 9,006 21,359 10,414 56,277    5,070 5,070 2,300 2,925  1,380    1,765     4,375  
      total operating expense
    		5,238,000 5,673,000 5,086,000  8,882,556 8,809,742 5,873,187 3,481,793 3,436,443 3,161,613 3,835,673                                         
      income from operations
    		-1,698,000 -1,181,000 -1,501,000  -1,502,577 -1,497,569 -1,328,583 -1,102,283 -1,215,600 -1,122,956 -1,658,383 -1,929,550 -2,244,076 -442,393 -1,217,893 -1,510,686 -653,836 -782,524 -1,327,570 -935,390 -621,048 -997,272 -1,230,920 -736,118 -5,634,559 -714,303 -2,106,696 -331,816 -40,127 -73,231 -49,849 -56,277 -2,172,861 -6,759 -3,845 -5,070 -5,070 -2,300 -2,925 -12,070 -1,380  -1,260 -1,375 -1,765 -4,583  -1,600 -3,224 -4,375 -8,684 
      yoy
    		13.01% -21.14% 12.98%  23.61% 33.36% -19.89% -42.87% -45.83% 153.84% 36.17% 27.73% 243.22% -43.47% -8.26% 61.50% 5.28% -21.53% 7.85% 27.07% -88.98% 39.61% -41.57% 121.85% 13941.81% 875.41% 4126.15% 489.61% -98.15% 983.46% 1196.46% 1010.00% 42757.22% 193.87% 31.45% -58.00% 267.39%  132.14% 777.82% -21.81%   -14.06% -45.25% 4.75%      
      qoq
    		43.78% -21.32%   0.33% 12.72% 20.53% -9.32% 8.25% -32.29% -14.05% -14.02% 407.26% -63.68% -19.38% 131.05% -16.45% -41.06% 41.93% 50.61% -37.73% -18.98% 67.22% -86.94% 688.82% -66.09% 534.90% 726.91% -45.20% 46.91% -11.42% -97.41% 32047.67% 75.79% -24.16% 0.00% 120.43% -21.37% -75.77% 774.64%   -8.36% -22.10% -61.49%   -50.37% -26.31% -49.62%  
      operating margin %
    		-Infinity% -Infinity% -Infinity% NaN% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -661679.10% -1266193.03% -430303.01% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity%  -Infinity% -Infinity% -Infinity% -Infinity%  -Infinity% -Infinity% -Infinity% -Infinity% 
      other income:
    		                                                   
      interest expense
    		-538,000 -486,000 -490,000  -381,663 -325,982 -241,888 -100,281 -104,276 -110,130 -557,479 -660,942 -3,727,168 -1,877,149 -396,435 -408,650 -473,360 -97,484 -173,882 -136,627 -98,766 -88,343 -208,494 -31,539 -144,023 -19,649 -10,525 -5,533 -4,288 -4,288 -4,472 -3,983 -66,530 -437 -387 -363 -363               
      loss on extinguishment of debt
    		 -125,000   -745,439 -38,587 -255,685 -305,891 -89,341  -304,828        -32,500  -406,833                               
      other income
    		 29,000   290 266 109 -1,256 -4,800 -206 -616 -194,971 194,744 111 1,765                                     
      fair value adjustment for contingent consideration
    		 4,000 2,000  179,451 21,644 -2,845 -1,425 69,305 98,979 27,175                                         
      total other expense
    		-538,000 -578,000 -488,000  -947,361 -342,659 -500,309 -393,311 -113,057 -7,894 -887,404 -1,428,083 -2,181,736 -3,917,947 -337,076           -19,649 -10,525                         
      net income
    		-2,236,000 -1,759,000 -1,989,000  -2,449,938 -1,840,228 -1,828,892 -1,495,594 -1,328,657 -1,134,050 -2,545,787 -3,360,033 -4,425,812 -4,360,340 -1,554,969 -977,850 -858,747 -864,273 -1,501,758 -1,175,291 -1,126,647 -1,085,615 -1,439,414 -767,657 -5,778,582 -733,952 -2,117,221 -337,349 -44,415 -77,519 -54,321 -60,260 -2,239,391 -7,196 -4,232 -5,433 -5,433 -2,300 -2,925 -12,070 -1,380  -1,260 -1,375  -4,583  -1,600 -3,224 -4,375 -8,684 
      yoy
    		-8.73% -4.41% 8.75%  84.39% 62.27% -28.16% -55.49% -69.98% -73.99% 63.72% 243.61% 415.38% 404.51% 3.54% -16.80% -23.78% -20.39% 4.33% 53.10% -80.50% 47.91% -32.01% 127.56% 12910.43% 846.80% 3797.61% 459.82% -98.02% 977.25% 1183.58% 1009.15% 41118.31% 212.87% 44.68% -54.99% 293.70%  132.14% 777.82%    -14.06%  4.75%      
      qoq
    		27.12% -11.56%   33.13% 0.62% 22.29% 12.56% 17.16% -55.45% -24.23% -24.08% 1.50% 180.41% 59.02% 13.87% -0.64% -42.45% 27.78% 4.32% 3.78% -24.58% 87.51% -86.72% 687.32% -65.33% 527.61% 659.54% -42.70% 42.71% -9.86% -97.31% 31019.94% 70.04% -22.11% 0.00% 136.22% -21.37% -75.77% 774.64%   -8.36%     -50.37% -26.31% -49.62%  
      net income margin %
    		-Infinity% -Infinity% -Infinity% NaN% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -690028.76% -1298557.75% -442139.76% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity%  -Infinity% -Infinity% NaN% -Infinity%  -Infinity% -Infinity% -Infinity% -Infinity% 
      net income per share
    		-0.81 -0.66 -0.81  -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.03 -0.04 -0.05 -0.02                                     
      weighted-average number of shares of common stock outstanding – basic and diluted
    		2,759,771 2,660,435 2,445,471 1,989,134 214,527,261 205,106,912 186,933,622 157,933,458 161,587,934 159,997,395 135,099,173   85,395,846 68,373,226 52,517,530                                    
      change in fair value of derivative liabilities
    		       15,542 16,055 3,463 -51,656 697,687 1,350,688 -2,040,909 57,594                                     
      provision for income taxes
    		         3,200                                          
      income before provision for income taxes
    		       -1,495,594 -1,328,657 -1,130,850                                          
      other income and
    		                                                   
      net revenues:
    		                                                   
      license revenues
    		           250   1,000                                     
      net revenues
    		           781,778 1,882,129 1,019,520 225,463 175,648 179,744 183,473                                  
      operating expenses:
    		                                                   
      total operating expenses
    		           1,757,868.5 4,126,205 1,461,913 1,443,356 1,929,142 731,221 901,968 1,524,422 1,242,544 1,064,135 1,060,510 1,341,157 740,493 5,635,004 714,469 2,106,975 331,816 40,127 73,231 49,849 56,277    5,070 5,070 2,300 2,925 12,070            
      weighted-average number of shares of common stock outstanding –   basic and diluted
    		            104,972,645                                       
      cost of goods sold
    		               60,702 102,359     50,546 55,851    117                         
      operating expenses
    		                                                   
      change in fair value of derivative liability
    		               79,094.5 268,449 15,735 32,194                                 
      basic loss and diluted loss per share
    		               -0.015 -0.02 -0.02 -0.04 -0.05 -0.05 -0.05  -0.04  -0.04  -0.02    -0.04                    
      weighted-average number of shares outstanding – basic and diluted
    		                55,076,819 40,816,767                                  
      cost of goods cold
    		                 64,029                                  
      revenues
    		                  196,852 180,739.75 443,087 113,784 166,088    396                         
      weighted-average number of shares outstanding- basic and diluted
    		                  34,970,677 24,384,037    17,329,899                            
      licensing revenues
    		                   25,000 325,000                               
      weighted-average number of shares outstanding - basic and diluted
    		                    24,383,486 23,807,965                              
      basic loss and diluted
    		                                                   
      loss per share
    		                      -0.06    -0.12                         
      weighted-average
    		                                                   
      number of shares
    		                                                   
      outstanding- basic and diluted
    		                      22,540,119                             
      total revenues
    		                       111.25 445 166                          
      yoy
    		                                                   
      qoq
    		                       -75.00% 168.07%                           
      investment banking fees
    		                        1,954,865                           
      total other income
    		                       -8,926.75 -144,023                           
      weighted-average number of shares outstanding
    		                         17,848,558  16,425,560 11,999,597 16,333,670 13,764,648 1,352,004    13,251,250 13,251,250 13,251,250 13,251,250  13,251,250    13,251,250       
      other expense
    		                                                   
      stock compensation
    		                          1,612,647                         
      outstanding
    		                          16,973,163             13,251,250   3,312,812.5 13,251,250  13,251,250   13,251,250  13,251,250 
      professional fees
    		                           219,014 29,121 51,872 39,435                     
      compensation
    		                           69,863                        
      income before income taxes
    		                           -337,349 -44,415 -77,519   -2,239,391 -7,196 -4,232 -5,433 -5,433 -2,300 -2,925 -12,070 -1,380  -1,930.75 -1,375 -1,765 -4,583      
      total other expenses
    		                            -3,185.75 -4,288 -4,472 -3,983    -363                
      other expenses
    		                                                   
      general and administrative expense
    		                                3,918.5 6,759 3,845                 
      discontinued operations
    		                                                   
      weighted-average number of
    		                                                   
      shares outstanding
    		                                3,312,812.5 13,251,250 13,251,250                 
      the accompanying notes are an integral part of these consolidated financial statements.
    		                                                   
      other incomes
    		                                                   
      total other incomes
    		                                    -363               
      benefit from income taxes
    		                                                   
      general and
    		                                                   
      administrative
    		                                       12,070   1,930.75 1,375  4,583  4,070.75 3,224  8,684 
      expenses
    		                                                   
      total expenses
    		                                        1,380    1,765 4,583  1,600 3,224 4,375 8,684 
      basic loss per share
    		                                                   
      weighted average
    		                                                   
      weighted average number of shares outstanding
    		                                                 13,251,250  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-03-31 2002-01-01 
                                                      
        assets
      		                                                
        assets:
      		                                                
        cash
      		955,000 1,574,000 1,947,000 1,248,000 703,012 1,614,495 4,923,796 1,564,859 1,315,059 1,824,633 2,375,352 829,933 1,454,545 198,133 32,553 55,901 149,521 16,417 56,177 7,479 6,861 44,627 114,323 33,374 25,876 137,579 112,759 18,445 33,145 105,726 59,961                  
        accounts receivable
      		117,000 319,000 130,000 282,000 356,347 287,350 195,242 68,259 27,526 21,148 15,075 33,575 30,875 22,147 45,181 83,097 68,229 37,885 81,148 191,601 428,320 153,134 210,869 216,641 75,165 280                       
        prepaid expense and other current assets
      		1,539,000 1,711,000 1,574,000 1,116,000 1,265,474 693,930 333,136 363,080 265,217 394,273 592,644 863,664                                     
        inventories
      		1,742,000 1,853,000 2,130,000 2,370,000 2,198,045 2,229,183 1,648,730 1,725,698 640,055 586,455 536,640 599,856 396,772 222,437 272,430 254,443                                 
        total current assets
      		4,353,000 5,457,000 5,781,000 5,016,000 4,522,878 4,824,958 7,100,904 3,721,896 2,247,857 2,826,509 3,519,711 2,327,028 3,061,404 1,785,531 378,334 544,296 701,391 426,002 511,589 520,063 728,178 435,670 566,675 484,338 122,241 143,998 112,759 18,445 33,145 105,726 59,961                  
        property and equipment
      		216,000 227,000 229,000 247,000 206,425 178,669 203,385 62,454 31,442 32,197 29,003 29,569 32,235 34,296 37,980 35,101 52,608 59,733                               
        deposits
      		21,000 21,000 21,000 21,000 20,881 20,881 20,881 20,881 14,958 14,958 14,958 14,958 14,958     17,391 17,391 21,919 21,919 21,919 21,919 21,200  3,200                       
        operating lease right-of-use asset
      		593,000 622,000 649,000                                              
        goodwill
      		953,000 953,000 953,000 953,000 952,576 952,576 952,576 952,576 952,576 952,576 952,576 952,576 549,368 549,368 549,368 549,368 549,368 549,368 549,368 429,225 421,372 421,372 421,372 421,372                         
        intangible assets
      		3,378,000 3,557,000 3,736,000 3,890,000 3,800,674 3,958,151 4,115,624 4,273,099 4,430,572 4,588,049 4,745,522 4,903,247 5,401,571 5,579,653 5,757,736 5,300,859 5,464,637 5,612,067 5,756,026 1,055,372 1,035,523 1,062,788 1,097,494  4,149                        
        total assets
      		9,514,000 10,837,000 11,369,000 10,127,000 9,503,434 9,935,235 12,393,370 9,030,906 7,677,405 8,414,289 9,261,770 8,227,378 9,059,536 8,001,266 6,738,376 6,444,582 6,782,962 6,647,170 6,885,478 2,081,090 2,270,357 1,991,364 2,165,230 2,113,433 376,390 393,998 112,759 18,445 33,145 105,726 59,961                  
        liabilities and stockholders' equity
      		                                                
        liabilities:
      		                                                
        accounts payable and accrued expenses
      		3,691,000            1,623,547 1,084,928 861,772 691,365 595,720 507,464 383,568 362,160 258,712 248,427 245,653                          
        operating lease liability
      		162,000 155,000                                               
        accrued compensation
      		1,341,000 1,648,000 1,480,000  1,027,068 745,895 1,288,209 1,118,293 1,201,187 1,540,224 1,450,196 767,689 517,846     1,276,077 1,042,872 906,928 791,141 665,333 554,614 395,667 281,582 173,676                       
        deferred revenue and customer deposits
      		170,000 83,000 282,000 108,000 95,372 97,950 142,769 24,690  46,769 11,000 11,000 11,000 7,754 7,754 24,079                                 
        accrued interest payable
      		57,000 38,000 35,000 32,000 24,232 22,168 11,671 3,648 21,353 20,587 12,289 47,782 30,656 77,125 109,790 79,113 60,622 105,809 85,675 52,568 34,898 32,724 14,986 3,224 34,957 5,392 17,581 16,596 12,308 8,020 3,983                  
        short-term loan payable
      		553,000 681,000 422,000  138,048 132,197 32,775  57,590                                        
        notes payable, net of debt discount of 424 and 1,008, respectively
      		2,762,000                                                
        total current liabilities
      		8,736,000 7,875,000 7,248,000 7,353,000 6,156,256 6,096,116 6,707,465 5,145,629 3,487,763 3,849,288 3,657,353 4,031,082 4,220,862 3,812,035 3,559,444 2,729,188 1,917,572 1,325,743 1,136,952 753,970 1,930,857 1,819,784 1,400,735 1,088,216 442,185 406,359 572,828 230,866 226,151 221,213 234,062   52,836 48,066 45,916 43,391 31,621 30,641 30,516 29,141 27,376 22,793 21,193 17,969 13,594 13,594  
        deferred rent
      		   181,000                                             
        operating lease liability, net of current portion
      		591,000 634,000 676,000                                              
        accrued compensation, net of current portion
      		935,000 1,032,000                                               
        contingent consideration
      		1,248,000 1,250,000    19,297 32,883 28,573 54,959 75,699 138,399 170,015 22,104 336,813 320,063  3,229,804 3,229,804 3,229,804 324,379 308,273 308,273 308,273 308,273                         
        total non-current liabilities
      		2,774,000 2,916,000 3,060,000 2,665,000 2,489,009 2,668,460 2,980,869 2,982,334 2,967,403 2,520,379 2,556,658 3,102,323 4,846,303 4,367,429 4,438,760  4,555,700 4,886,655 4,627,942 1,753,167 320,873 308,273 320,407 1,083,286 576,977 383,472                       
        total liabilities
      		11,510,000 10,791,000 10,308,000 10,018,000 8,645,265 8,764,576 9,688,334 8,127,963 6,455,166 6,369,667 6,214,011 7,133,405 9,067,165 8,179,464 7,998,204  6,473,272 6,212,398 5,764,894 2,507,137 2,251,730 2,128,057 1,721,142 2,171,502 1,016,418 789,831                       
        commitments and contingencies
      		                                                
        stockholders’ equity:
      		                                                
        preferred stock: 7,500,000 shares authorized, at 0.001 par value...
      		                                                
        common stock: 292,500,000 shares authorized, at 0.001 par value...
      		3,000 2,000 2,000 2,000 208,169 194,759 192,555 167,421 155,439 151,028 150,517 121,694                                     
        additional paid-in capital
      		47,845,000 47,652,000 46,908,000 43,967,000 42,350,286 40,226,248 39,922,601 36,375,359 35,211,043 34,709,180 34,578,778 30,108,028 25,663,922 20,611,715 15,662,183  14,720,194 13,991,924 13,813,532 10,778,807 10,049,100 8,769,420 8,264,806 6,531,110 4,979,226 4,489,901 2,309,745 2,220,202 2,733,183 2,733,183 2,606,195 3,216,591 3,215,154 3,214,327 3,213,664 3,213,514 3,213,114 3,212,814 3,212,414 3,211,114 3,211,114   3,211,114 3,211,114 3,211,114 3,211,114  
        accumulated deficit
      		-49,844,000 -47,608,000 -45,849,000 -43,860,000 -41,700,286 -39,250,348 -37,410,120 -35,639,837 -34,144,243 -32,815,586 -31,681,536 -29,135,749 -25,775,716 -21,349,904 -16,989,564  -14,456,745 -13,597,998 -12,733,725 -11,231,967 -10,056,676 -8,930,029 -7,844,414               -3,257,686 -3,256,306 -3,254,881         
        total stockholders' equity
      		-1,996,000 46,000 1,061,000 109,000 858,169 1,170,659 2,705,036 902,943 1,222,239 2,044,622 3,047,759 1,093,973     309,690 434,772 1,120,584 -426,047 18,627  444,088      -193,006 -115,487 -203,027   -52,836 -48,066 -45,916 -43,391 -31,621 -30,641 -30,516  -27,376 -22,793 -21,193 -17,969 -13,594 -13,594  
        total liabilities and stockholders’ equity
      		9,514,000 10,837,000 11,369,000 10,127,000 9,503,434 9,935,235 12,393,370 9,030,906 7,677,405 8,414,289 9,261,770             2,113,433                         
        accounts payable and accrued expense
      		 2,949,000 2,799,000 2,622,000 2,530,687 3,262,213 2,910,282 2,607,121 1,356,057 1,256,551 1,149,752 1,210,050                                     
        notes payable, net of debt discount of 813 and 1,008, respectively
      		 2,321,000                                               
        notes payable, net of debt discount of 736 and 1,008, respectively
      		  2,230,000                                              
        accrued compensation – less current portion
      		  1,130,000 1,228,000 1,227,554 1,227,554 1,531,904 1,531,904 1,531,904 1,036,315 1,036,315 1,531,904 1,506,010 906,928 906,928                                  
        contingent consideration – less current portion
      		  1,254,000 1,256,000 1,261,455 1,440,906 1,448,965 1,450,430 1,435,499 1,484,064 1,520,343 1,515,902 3,207,700 3,229,804 3,229,804                                  
        net revenue:
      		                                                
        product sales
      		  5,189,000 22,879,000 6,956,861                                            
        service revenue
      		  100,000 509,000 189,462                                            
        cooperative marketing revenue
      		  71,000 593,000 233,074                                            
        license revenue
      		  3,000 9,000 582                                            
        net revenue
      		  5,363,000 23,990,000 7,379,979                                            
        cost of product sales
      		  1,778,000 4,325,000 1,536,792                                            
        gross profit
      		  3,585,000 19,665,000                                             
        operating expense:
      		                                                
        research and development
      		  56,000 160,000 59,201                                            
        sales and marketing
      		  2,595,000 17,206,000 5,263,533                                            
        general and administrative
      		  2,435,000 7,991,000 2,023,030                                            
        total operating expense
      		  5,086,000 25,357,000 8,882,556                                            
        income from operations
      		  -1,501,000 -5,692,000 -1,502,577                                            
        other income:
      		                                                
        interest expense
      		  -490,000 -1,446,000 -381,663                                            
        loss on extinguishment of debt
      		   -1,332,000 -745,439                                            
        fair value adjustment for contingent consideration
      		  2,000 204,000 179,451                                            
        total other income
      		  -488,000 -2,587,000 -947,361                                            
        net income
      		  -1,989,000 -8,279,000 -2,449,938                                           -3,245,558 
        net income per share
      		  -810 -4,160 -0.01                                            
        weighted-average number of shares of common stock outstanding – basic and diluted
      		  2,445,471,000 1,989,134,000 214,527,261                                            
        accrued compensation - current portion
      		   1,252,000                                             
        derivative liabilities – warrants
      		       58,609 74,151 90,206 93,669 164,070 239,049 181,098 296,593 432,793                                 
        short-term loans payable
      		   266,000    65,399      71,156 137,731 230,351                                 
        current portion of notes payable, net of debt discount of 1,008 and 437, respectively
      		   3,073,000                                             
        other income
      		   -13,000 290                                            
        change in fair value of derivative liabilities
      		                                                
        income before benefit from income taxes
      		   -8,279,000                                             
        benefit from income taxes
      		                                                
        notes payable, net of debt discount of 830,610 and 437,355, respectively
      		    2,340,849                                            
        notes payable, net of debt discount of 612,615 and 437,355, respectively
      		     1,816,396                                           
        notes payable, net of debt discount of 929,353 and 437,355, respectively
      		      2,288,876                                          
        derivative liabilities – embedded conversion features
      		           319,674 1,091,544 1,409,664                                   
        current portion of notes payable, net of debt discount of 437,355 and 216,403, respectively
      		       1,239,296                                         
        convertible debentures, net of debt discount of 0 and 845,730, respectively
      		                                                
        notes payable, net of current portion and debt discount of 0 and 468, respectively
      		                                                
        current portion of notes payable, net of debt discount of 71,531 and 216,403, respectively
      		        722,466                                        
        current portion of notes payable, net of debt discount of 104,788 and 216,403, respectively
      		         819,252                                       
        current portion of notes payable, net of debt discount of 193,262 and 216,403, respectively
      		          802,048                                      
        current assets
      		                                                
        other assets
      		                                                
        current liabilities
      		                                                
        current portion of notes payable and non-convertible debenture, net of debt discount of 216,403 and 0, respectively
      		           626,610                                     
        line of credit convertible debenture and non-convertible debenture – related parties, net of debt discount of 0 and 17,720, respectively
      		                                                
        convertible debentures, net of debt discount of 845,730 and 1,050,041, respectively
      		           714,192                                     
        non-current liabilities
      		                                                
        notes payable and non-convertible debenture, net of current portion and debt discount of 468 and 0, respectively
      		           54,517                                     
        line of credit convertible debenture and non-convertible debenture – related parties, net of current portion
      		                                                
        stockholders' equity
      		                                                
        total liabilities and stockholders' equity
      		           8,227,378     6,782,962 6,647,170 6,885,478 2,081,090 2,270,357  2,165,230      33,145 105,726 59,961                  
        prepaid expenses and other current assets
      		            1,179,212                                    
        liabilities and stockholders' deficit
      		                                                
        current portion of note payable and non-convertible debenture, net of debt discount of 3,750 and 0, respectively
      		            274,536  320,467                                  
        line of credit convertible debenture and non-convertible debenture –  related parties, net of debt discount of 0 and 17,720, respectively
      		                                                
        convertible debentures, net of debt discount of 1,474,342 and 1,050,041, respectively
      		            410,580                                    
        note payable and non-convertible debenture, net of current portion and debt discount of 1,405 and 0, respectively
      		            132,593                                    
        stockholders' deficit
      		                                                
        common stock: 150,000,000 shares authorized, at 0.001 par value...
      		            104,165 87,177 67,553  46,241  40,777 27,113 26,203 23,916  21,549                         
        total stockholders' deficit
      		            -7,629 -178,198 -1,259,828          -640,028 -395,833 -460,069 -212,421                     
        total liabilities and stockholders' deficit
      		            9,059,536 8,001,266 6,738,376          376,390 393,998 112,759 18,445                     
        restricted cash
      		             1,305,000                                   
        prepaid expenses
      		             37,814 28,170 53,278 37,674 63,220 84,283 55,024 62,994 37,105 33,317 35,272 21,200 2,939                       
        security deposits
      		             52,418 14,958 14,958 14,958                                
        current portion of note payable and non-convertible debentures, net of debt discount of 3,750 and 0, respectively
      		             333,750                                   
        line of credit convertible debenture and non-convertible debenture – related parties, net of debt discount of 5,445 and 17,720, respectively
      		             309,747                                   
        current portion of convertible debentures, net of debt discount of 0 and 1,050,041, respectively
      		                                                
        note payable and non-convertible debentures, net of current portion and debt discount of 2,343 and 0, respectively
      		             230,697                                   
        line of credit convertible debenture and non-convertible debentures – related parties, net of current portion
      		              25,000                                  
        convertible debentures, net of debt discount of 1,650,000 and 0, respectively
      		                                                
        common stock subscribed but unissued
      		             472,814                                   
        derivative liabilities – embedded conversion feature
      		              380,385 301,779                                 
        line of credit convertible debenture and non-convertible debenture – related parties, net of debt discount of 9,282 and 17,720, respectively
      		              357,410                                  
        convertible debentures, net of debt discount of 690,021 and 1,050,041, respectively
      		              767,479                                  
        note payable and non-convertible debenture, net of current portion and debt discount of 3,281 and 0, respectively
      		              277,028                                  
        deferred financing costs
      		               97,577 134,763                                
        current portion of notes payable and convertible debentures, net of debt discount of 55,982 in 2014
      		               73,200                                 
        line of credit convertible debenture and non-convertible debenture – related parties, net of debt discount of 17,720 in 2015
      		               391,472                                 
        convertible debentures, net of debt discount of 952,464 in 2015
      		               505,036                                 
        inventory
      		                311,204 291,089 272,590 265,959 230,003 200,804 208,166 177,851                         
        deferred revenue
      		                7,754 7,754 17,586 25,224 125,220 150,220 150,281 175,569 75,136                        
        derivative liabilities
      		                556,542                                
        short-term loans, credit cards payable and other
      		                146,697                                
        warrant liability
      		                255,161 178,368 194,103                              
        notes payable, net of debt discount of 0 in 2015 and 55,982 in 2014
      		                119,066                                
        note payable, related party
      		                25,000                                
        debentures - current portion
      		                151,010                                
        accrued compensation – less short-term portion
      		                906,928                                
        notes payable, net of debt discount of 67,726 in 2014
      		                                                
        debentures, net of debt discount of 1,277,700 in 2015 - less current portion
      		                28,790                                
        debentures - related parties, net of debt discount of 34,014 and 76,492 in 2015 and 2014
      		                390,178                                
        notes payable, net of debt discount of 120,085 in 2015 and 55,982 in 2014.
      		                 359,915                               
        debentures - related parties (current portion), net of debt discount of 68,926 in 2015
      		                 150,108                               
        customer deposits
      		                 16,325                               
        debentures - related parties, net of debt discount of 29,384 and 76,492 in 2015 and 2014
      		                 380,774                               
        common stock: 150,000,000 shares authorized,
      		                                                
        at 0.001 par value...
      		                                                
        shares issued and outstanding, respectively
      		                 40,846     23,696   17,657                       
        see accompanying notes to these condensed consolidated financial statements.
      		                                                
        property & equipment
      		                  68,495 54,511 63,365 49,615 57,770                          
        notes payable, net of debt discount of 164,088 in 2015 and 55,982 in 2014
      		                  305,912                              
        debentures - related parties (current portion) , net of debt discount of 82,926
      		                  150,108                              
        notes payable, net of debt discount of 67,726
      		                                                
        debentures - related parties , net of debt discount of 54,892 and 76,492
      		                  355,266                              
        notes payable, net of debt discount of 55,982 in 2014 and 0 in 2013
      		                   314,018                             
        notes payable, net of debt discount of 67,726 in 2014 and 0 in 2013
      		                   24,274                             
        debentures - related parties (non-current portion), net of debt discount of 76,492
      		                   497,586                             
        debentures- related parties
      		                    478,399 242,125                           
        notes payable, net of debt discount of 127,513 in 2014 and 0 in 2013
      		                    242,487                            
        notes payable, net of debt discount of 79,400 in 2014 and 0 in 2013
      		                    12,600                            
        convertible debentures - related parties, net of debt discount of 149,678
      		                                                
        notes payable, net of debt discount of 199,045 in 2014 and 0 in 2013
      		                     480,955                           
        convertible debentures - related parties (non-current portion), net of debt discount of 149,678
      		                                                
        stockholders' (deficit) equity
      		                                                
        total stockholders' (deficit) equity
      		                     -136,693                           
        total liabilities and stockholders' (deficit) equity
      		                     1,991,364                           
        notes payable, net of debt discount of 269,799 in 2014 and 0 in 2013
      		                      435,201                          
        convertible debentures - related parties (non-current portion),
      		                                                
        net of debt discount of 149,678
      		                                                
        property & equipment, net of accumulated depreciation of
      		                       78,973                         
        intangible assets, net of accumulated amortization
      		                       873,567                         
        circumserum license, net of accumulated amortization
      		                       233,264                         
        liabilities and stockholders’ equity
      		                                                
        accounts payable
      		                       143,756 62,723 94,298 58,616 1,602 1,175 525 5,411  1,800 3,975    275 210          
        promissory notes
      		                       370,000 20,000   50,000 50,000 50,000 50,000                  
        convertible debentures - related parties (non-current portion), net of debt discount
      		                       511,465                         
        deficit accumulated during the development stage
      		                       -6,405,000 -5,637,343 -4,903,391 -2,786,170 -2,448,821 -2,942,523 -2,865,004 -2,810,683 -3,291,842 -3,284,646 -3,280,414 -3,274,981 -3,272,681 -3,269,756    -3,253,506 -3,251,741 -3,247,158 -3,245,558 -3,242,334 -3,237,959 -3,237,959  
        total stockholders’ equity
      		                       147,659                 -29,141        
        circumserum license
      		                        250,000 250,000                       
        accrued interest
      		                        2,744                        
        convertible debentures - related parties
      		                        539,276 90,000 426,768                      
        common stock; 150,000,000 shares authorized, at 0.001 par value...
      		                        18,089  16,356 16,198 16,334 16,334 1,461                  
        convertible debt - related party, net of discount of 7,007 and 0, respectively
      		                         42,993                       
        common stock; 150,000,000 shares authorized,
      		                                                
        accrued salary
      		                          69,863                      
        convertible debentures - related party
      		                           162,668 162,668 162,668 174,668                  
        related-party payables
      		                                                
        contigent liability related to common shares, subject to recsission rights, issuable to fastrack shareholders arising from merger
      		                                                
        contigent liability related to common shares, subject to recssision rights, issuable to fastrack shareholders arising from merger
      		                              28,926                  
        related-party payable
      		                               62,000 54,441 48,861 48,066 45,916 43,391 31,346  30,516         
        common stock; 80,000,000 shares authorized,
      		                                                
        shares issued and outstanding
      		                               13,251 13,251    13,251   13,251    13,251 13,251 13,251 13,251  
        the accompanying notes are an integral part of these consolidated financial statements.
      		                                                
        common stock; 80,000,000 shares authorized, at 0.001 par value...
      		                                 13,251 13,251   13,251 13,251  13,251        
        common stock; 80,000,000 shares authorized,at 0.001 par value...
      		                                   13,251             
        total liabilities and stockholders'
      		                                                
        equity
      		                                                
        related party payable
      		                                      30,431  29,141 27,376 22,793 21,193 17,969 13,594 13,594  
        stockholders’ equity
      		                                                
        issued and outstanding
      		                                         13,251 13,251      
        additional paid in capital
      		                                         3,211,114       
        cash flows from operating activities
      		                                                
        adjustments to reconcile net income to net cash
      		                                                
        used by operating activities:
      		                                                
        common stock issued for services
      		                                               976 
        changes in operating assets and liabilities:
      		                                                
        increase in accounts payable
      		                                                
        increase in related party payables
      		                                               24,582 
        net cash used by
      		                                                
        operating activities
      		                                               -3,220,000 
        cash flows from investing activities
      		                                                
        cash flows from financing activities
      		                                                
        sale of common stock
      		                                               3,220,000 
        net cash provided by
      		                                                
        financing activities
      		                                               3,220,000 
        net decrease in cash
      		                                                
        cash at beginning of period
      		                                                
        cash at end of period
      		                                                
        supplimental disclosures of cash flow information
      		                                                
        cash paid for:
      		                                                
        interest
      		                                                
        income taxes
      		                                                
        non cash financing activities:
      		                                                
        common stock issued for debt
      		                                               3,389 
        exhibits
      		                                                
        no.
      		                                                
        3
      		                                                
        31.1
      		                                                
        31.2
      		                                                
        32.1
      		                                                
        32.2
      		                                                
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-10-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2011-01-01 2010-01-01 
                                     
          cash flows from operating activities:
        		                             
          net loss
        		-2,236,000 -1,759,000 -1,989,000 -2,159,942 -2,449,938 -1,840,228 -1,828,892 -1,495,594 -1,328,657 -1,134,050 -2,545,787 -3,360,033 -4,425,812 -4,360,340 -1,554,969 -3,224,778 -864,273 -1,501,758 -1,175,291     -733,952 -2,117,221 -337,349 -77,519   
          adjustments to reconcile net loss to net cash from operating activities:
        		                             
          depreciation
        		17,000 18,000 17,000    6,991 3,493 2,838 2,598 2,822 -3,899 2,061 3,684 3,686 24,943 8,762 9,053 47,842 -13,750 8,155 21,203        
          recovery of allowance for doubtful accounts
        		-1,000 -4,000 -7,000                           
          common stock, restricted stock units and stock options issued to employees, board of directors and consultants for compensation and services
        		139,000 137,000 138,000 134,942 130,828 109,771 115,459 138,581 254,729 161,907 580,394                   
          loss on extinguishment of debt
        		0   292,288 745,440 38,587 255,685 305,891 89,341 0 304,828     32,500 0 32,500            
          change in fair value of contingent consideration
        		0 -4,000 -2,000 -5,750 -179,450 -21,645 2,845 1,425 -69,305 -98,979 -27,175                   
          amortization of debt discount
        		480,000 447,000 461,000 470,105 364,803 304,688 229,404 90,456 86,250 88,474 512,874 649,100   370,760 539,206              
          amortization of intangible assets
        		179,000 178,000 185,000 161,575 157,477 157,473 157,475 157,473 157,477 157,473 157,725 110,637 178,082 178,083 157,602               
          changes in operating assets and liabilities, net of acquisition amounts
        		                             
          accounts receivable
        		204,000 -185,000 158,000 74,909 -68,997 -92,108 -126,804 -42,710 -7,192 -7,771 15,922 -3,848 -3,938 23,034 32,208 123,372 43,263 110,453 236,719 -275,186 57,735 5,772  -74,885      
          prepaid expense and other current assets
        		173,000 -138,000 -458,000 54,346 -433,496 -360,794 29,944 -64,781 88,845 -12,623 101,075                   
          inventories
        		110,000 278,000 552,000 -69,653 31,138 -580,453 76,968 -1,085,643 -53,600 -49,815 63,216 -203,084 -174,335 49,993 -17,987               
          operating lease right-of-use asset and liability
        		-7,000 -7,000 -7,000                           
          accounts payable and accrued expense
        		703,000 271,000 30,000 50,647 -731,526 351,931 121,948 1,251,064 99,506 286,799 119,702                   
          accrued compensation
        		-405,000 71,000 130,000 224,575 281,173 -846,664 169,916 -82,894 156,552 90,028 186,918 275,737     233,205 135,944 115,788 125,808 110,719 158,947  107,906      
          accrued interest payable
        		43,000 18,000 15,000 23,440 14,497 15,040 8,023 2,841 7,991 8,298 -22,383 20,931 -45,171 25,470 30,677 11,254              
          deferred revenue and customer deposits
        		87,000 -200,000 175,000 12,318 -2,578 -44,819 118,079 24,690 -46,769   0 3,246 0 -16,325               
          net cash from operating activities
        		-514,000 -754,000 -602,000 -533,113 -2,127,154 -2,797,595 -663,138 -815,196 -577,235 -473,657 -495,635 -1,044,786 -995,624 361,641 -105,489 -786,012 -36,596 -91,765 53,642 -359,787 -286,821 -248,304 -119,786 -215,062 -184,820 -119,786 -72,581 -795 -915 
          capital expenditures
        		-5,000 0 0 -61,936 -41,232 13,090 -147,922 -34,505 -2,083 -5,792 -2,256 0 0 0 -6,565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
          free cash flows
        		-519,000 -754,000 -602,000 -595,049 -2,168,386 -2,784,505 -811,060 -849,701 -579,318 -479,449 -497,891 -1,044,786 -995,624 361,641 -112,054 -786,012 -36,596 -91,765 53,642 -359,787 -286,821 -248,304 -119,786 -215,062 -184,820 -119,786 -72,581 -795 -915 
          cash flows from investing activities:
        		                             
          purchase of property and equipment
        		-5,000   -61,936 -41,232 13,090 -147,922 -34,505 -2,083 -5,792 -2,256                   
          asset acquisition
        		0                             
          contingent consideration payment
        		                             
          net cash from investing activities
        		-5,000 -16,000 -343,000 -298,638    -47,385    -15,538 -150,000   -12,816 -3,277 -9,537            
          cash flows from financing activities:
        		                             
          payments on short-term loans payable
        		-153,000 -434,000 -230,000 86,383 -187,181 -25,578 -32,624 -25,272    0 -71,156 -78,075 -102,920               
          proceeds from short-terms loans payable
        		0 678,000 375,000                           
          proceeds from notes payable
        		1,000,000 1,250,000 400,000  1,849,999 0 1,872,500    150,000     130,000 0 100,000            
          payments on notes payable
        		-947,000 -1,097,000 -1,615,000 -645,584 -402,568 -624,218 -508,630 -212,347 -75,042 -71,270 -67,688 -64,288 -158,256   -402,933              
          proceeds from sale of common stock and warrants, net of offering costs
        		0 0 2,714,000     0 0 0 3,307,773                   
          proceeds from stock option and warrant exercises
        		      2,838,751 0                      
          net cash from financing activities
        		-100,000 397,000 1,644,000 1,376,599 1,276,200 -524,796 4,169,997 1,082,381 69,744 -71,270 2,043,310 435,712 2,402,036 -196,061 88,706 940,870 113 150,000 8,511 322,021 217,125 329,253 214,100 107,508 209,640 214,100 0 795 915 
          net change in cash
        		-619,000 -373,000 699,000 544,847 -911,483 -3,309,301 3,358,937 249,800 -509,574 -550,719 1,545,419 -624,612 1,256,412 165,580 -23,348 142,042 -39,760 48,698 619 -37,766 -69,696 80,949 94,314 -111,703 24,820 94,314 -72,581   
          cash at beginning of period
        		0 0 1,248,000  0 0 1,564,859  0 0 829,933  0 0 55,901 7,479 0 7,479 -1 0 0 33,374 18,445 0 0 18,445 0   
          cash at end of period
        		-619,000 -373,000 1,947,000  -911,483 -3,309,301 4,923,796  -509,574 -550,719 2,375,352  1,256,412 165,580 32,553 149,521 -39,760 56,177 618 -37,766 -69,696 114,323 112,759 -111,703 24,820 112,759 -72,581   
          supplemental disclosures of cash flow information:
        		                             
          cash paid for interest
        		0 8,000 21,000                           
          supplemental disclosures of non-cash investing and financing activities:
        		                             
          common stock issued for conversion of convertible debentures, notes payable and accrued interest
        		0                             
          relative fair value of common stock issued in connection with notes payable recorded as debt discount and settlement of contingent consideration
        		                             
          fair value of common stock issued to consultants for services
        		53,000                             
          offering costs in connection with warrant exercises included in accounts payable and accrued expense
        		                             
          cumulative adjustment to accumulated deficit for the fair value of the warrant derivative liability upon adoption of asu 2017-11 on january 1, 2018
        		                             
          fair value of common stock issued as financing fees in connection with notes payable recorded as debt discount
        		0 28,000 28,000                           
          relative fair value of common stock issued in connection with notes payable recorded as debt discount
        		 306,000 61,000                           
          purchase of intangible assets
        		  -343,000                           
          cash paid for operating lease liabilities
        		  65,000                           
          allowance for doubtful accounts
        		       1,977 814 1,698 2,578 1,148 -4,790 0 5,708               
          change in fair value of derivative liabilities
        		       -15,542 -16,055 -3,463 51,656 -697,687 -1,350,688 2,040,909 -57,594               
          deposits
        		               9,394 -6,954.039 6,961            
          deferred rent
        		                             
          acquisitions, net of cash acquired
        		                             
          payment on contingent consideration
        		                             
          proceeds from short-term loans payable
        		   188,000 0       0 0 11,500 10,300               
          proceeds from notes payable and convertible debentures
        		       1,350,000 150,000   500,000 2,657,500                 
          issuance of common stock for services
        		   0                          
          payments on convertible debentures
        		       0 0 0 -1,222,422                   
          prepayment penalty on extinguishment of convertible debentures
        		       0 0 0 -127,247                   
          cash at beginning of year
        		                             
          cash at end of year
        		                             
          depreciation & amortization
        		    13,476                         
          (recovery of) allowance for doubtful accounts
        		    0 0 -179                       
          proceeds from warrant and stock option exercises
        		    13,950                         
          cash paid for income taxes
        		                             
          common stock issued for conversion of convertible debentures and accrued interest
        		                             
          reclassification of the fair value of the embedded conversion features from derivative liability to additional paid-in capital upon conversion
        		                             
          fair value of non-forfeitable common stock issued to consultant included in accounts payable and accrued expense
        		                             
          offering costs in connection with warrant exercises included in accounts payable and accrued expenses
        		                             
          issuance of shares of common stock for vested restricted stock units
        		                             
          fair value of common stock issued for prepayment of future royalties due under the cri license agreement included in prepaid expense and other current assets
        		                             
          fair value of embedded conversion feature in convertible debentures in excess of allocated proceeds
        		            1,818,059                 
          repayments of line of credit convertible debenture – related party
        		              -42,500               
          financing costs in connection with convertible debentures
        		                             
          proceeds from stock option exercises
        		         0 2,894                   
          changes in operating assets and liabilities, net of acquisition amounts:
        		                             
          cash flows from operating activities
        		                             
          gain on purchase price adjustment to goodwill
        		                             
          impairment of goodwill
        		                             
          non-cash gain on settlement of contingent consideration
        		                             
          shares of common stock issued for debt amendment
        		                             
          fair value of embedded conversion feature in convertible  debentures in excess of allocated proceeds
        		                             
          cash flows from investing activities
        		                             
          payments on contingent consideration
        		                             
          cash flows from financing activities
        		                             
          financing costs in connection with issuance of convertible debentures
        		                             
          proceeds from warrant exercises
        		           0                  
          proceeds from non-convertible debentures – related party
        		                             
          payments on non-convertible debentures – related party
        		           0                  
          adjustments to reconcile net loss to net cash from operating activities
        		                             
          common stock, restricted stock units and stock options issued for services and board compensation
        		            665,896 484,295 739,646               
          stock issued for interest on debt amendment
        		               48,000              
          gain on return of shares of common stock issued in semprae merger
        		                             
          imputed interest on contingent consideration
        		            7,968 16,750 5,584               
          non-cash gain on contingent consideration
        		                             
          prepaid expenses and other current assets
        		                             
          accounts payable and accrued expenses
        		            549,481 208,156 170,407 233,558   95,593   101,897        
          payments on beyond human contingent consideration
        		                             
          proceeds from (repayments of) line of credit convertible debenture – related party
        		            -290,192                 
          amortization of debt discount and deferred financing costs
        		                             
          prepaid expenses
        		             -144 25,108 27,324 21,064 -19,286   -24,988 23,155  -18,261      
          security deposits
        		                             
          purchase of property & equipment
        		             0 -6,565               
          deferred financing costs in connection with convertible debentures
        		                             
          proceeds from note payable and convertible debentures
        		              242,500               
          payments on note payable
        		              -18,674               
          proceeds from non-convertible debentures - related party
        		                             
          gain of purchase price adjustment to goodwill
        		                             
          amortization of deferred financing costs
        		               16,156              
          net proceeds from (repayments of) line of credit convertible debenture – related party
        		                             
          proceeds from convertible debentures
        		               1,325,000           0   
          fees paid in connection with issuance of convertible debentures
        		               -82,500              
          payments on notes payable and convertible debentures
        		                             
          payment made on contingent consideration
        		                             
          payments on non-convertible debentures - related party
        		                             
          adjustments to reconcile net loss to net cash used by operating activities
        		                             
          stock based compensation
        		               831,807 121,192 630,518            
          common stock, stock units and stock options issued for services and board compensation
        		               457,186              
          change in fair value of derivative liability
        		               -316,378 -15,735 -32,194            
          gain on return of shares issued in semprae merger
        		               -115,822              
          excess of fair value of debentures over proceeds on new financing
        		               71,462              
          amortization of intangibles
        		               387,011 147,236 92,346 42,697 27,265          
          inventory
        		               -45,245 -18,499 -6,631 -35,956 -29,199 7,362 -30,315        
          short-term loans, credit cards and other current liabilities
        		               120,508              
          deferred revenue
        		               -17,470 -9,832 -7,638 -99,996 -25,000 -61 -25,288        
          purchase of equipment
        		               -9,540 0 -9,537            
          intangible assets
        		               -3,276              
          proceeds from convertible debenture - related party
        		               114              
          proceeds from short-term loans
        		               50,000              
          payments on short-term loans
        		               -23,811              
          proceeds from notes payable - related party
        		               50,000 0 50,000    25,000        
          payments on notes payable - related party
        		               -105,000              
          supplemental disclosures of cash flow information - fair value of:
        		                             
          common stock issued for conversion of debt
        		               167,000 0 92,000            
          common stock issued and issuable for acquisition
        		               2,071,625              
          common stock and cash potentially issuable for acquisition
        		               2,862,300              
          share return – semprae acquisition
        		               115,822              
          return of common stock shares related to license agreement
        		               38,000 0 38,000            
          shares issued in conjunction with debt amendment
        		               48,000              
          warrants issued as deferred financing costs
        		               68,419              
          fair value of warrants and conversion feature issued with convertible debentures
        		               1,137,250              
          common stock, stock units, and stock options issued for services
        		                55,148 264,553            
          accrued expenses
        		                140,221 21,408            
          interest payable
        		                20,134 33,107 17,670 28,593 17,112 22,978 985 12,063 9,515 985 4,288   
          proceeds from convertible debt
        		                  0           
          supplemental disclosures of
        		                             
          cash flow information - fair value of:
        		                             
          common stock issued and potentially issuable for acquisition
        		                0 4,977,050            
          beneficial conversion on line of credit
        		                2,120 2,034            
          adjustments to reconcile net loss to net cash used by operating activities:
        		                             
          debt discount
        		                 138,899            
          shares issued inconjuction with debt amendment
        		                 25,659            
          stock compensation
        		                     564,226  279,869      
          extinguishment of debt
        		                             
          acquisition of semprae inc, cash received
        		                             
          proceeds (repayment) from notes payable
        		                  0 40,000 0 300,000        
          proceeds from stock issued for cash
        		                       0   0   
          proceeds from debentures - related party
        		                  0 25,000          
          proceeds from loc convertible debt - related party
        		                             
          repayment of assumed debt related to acquistion of semprae
        		                             
          repayment of dawson james note
        		                             
          supplemental disclosures of cash flow information
        		                             
          common stock of 1,900,000 shares issued for extinguishment of debt
        		                  0           
          common stock of 1,855,747 shares issued for conversion of convertible debt
        		                  11,507 0 0 742,300        
          common stock of 142,857 shares issued for the purchase of vesele
        		                             
          common stock of 631,313 shares issued with the cri asset purchase agreement
        		                             
          common stock of 83,103 shares issued for conversion of convertible debt
        		                             
          common stock of 3,201,776 shares issued for acquisition of semprae laboratories, inc.
        		                             
          stock-based compensation
        		                   282,953          
          fair value of common stock, stock units, and stock options issued for services
        		                             
          prepaid expenses and deposits
        		                             
          proceeds from convertible debt - related party
        		                   207,021 117,125 4,253 264,100 346,608 -214,100 264,100    
          net income
        		                    -1,085,615 -1,439,414 -337,349     -5,433 -1,380 
          adjustments to reconcile net income to net cash used by operating activities:
        		                             
          accounts payable and accrueds
        		                             
          cash flow information
        		                             
          adjustments to reconcile net income to
        		                             
          net cash used by operating activities:
        		                             
          common stock and stock units issued for services
        		                     153,754        
          debt discount write-off in connection with conversion of notes payable
        		                     143,612        
          accretion of debt discount
        		                     41,832  7,008      
          amortization expense
        		                     9,337        
          3
        		                             
          common stock issued for services
        		                      89,701 158,430 106,290 89,701    
          value of warrants granted to investment banker
        		                             
          non-cash interest expense
        		                             
          promissory note issued for services rendered
        		                             
          research and development expense recognized upon purchase of ssao inhibitor assets
        		                             
          expenses paid on behalf of the company by apricus bio
        		                             
          accounts payable
        		                      57,014 -31,576 35,683 57,014 650 3,975  
          related-party payable
        		                             
          proceeds from issuance of loans from officers
        		                             
          repayment of loans from officers
        		                             
          proceeds from related-party settlement agreement
        		                             
          proceeds from convertible debt – related party
        		                             
          see note 8 for disclosure of non-cash financing activities
        		                             
          changes in operating assets and liabilities
        		                             
          accrued salaries
        		                      69,863   69,863    
          repayment of notes payable
        		                      -50,000 0 0 -50,000    
          f-4
        		                             
          adjustments to reconcile net loss to
        		                             
          non-cash interest expense (including a discount
        		                             
          on conversion of apricus bio convertible notes
        		                             
          of 48,920)
        		                             
          research and development expense
        		                             
          recognized upon purchase of ssao inhibitor assets
        		                             
          see note 9 for disclosure of non-cash financing activities
        		                             
          proceeds from convertible debentures - related party
        		                             
          see note 12 for disclosure of non-cash financing activities
        		                             
          change in related-party payable
        		                             
          income taxes payable
        		                             
          cash paid for:
        		                             
          interest
        		                             
          income taxes
        		                             
          see note 7 for disclosure of non-cash financing activities
        		                             
          investment banking fees - fair value of warrants granted
        		                             
          supplemental disclosures of cash flow information - see note 7 for disclosures of non-cash financing activities
        		                             
          non-cash interest expense (including a discount on conversion of
        		                             
          apricus bio convertible notes of 48,920)
        		                             
          net cash from
        		                             
          operating activities
        		                             
          repayments of loans from officers
        		                             
          proceeds from convertible notes payable
        		                             
          financing activities
        		                             
          interest paid
        		                             
          taxes paid
        		                             
          imputed interest
        		                           363  
          services contributed by shareholders
        		                           300 400 
          changes in operating assets and liabilities:
        		                             
          increase in related party payable
        		                           795  
          sale of common stock
        		                             
          non cash investing and financing activities
        		                             
          common stock issued for debt
        		                             
          exhibits
        		                             
          no.
        		                             
          31.1
        		                             
          31.2
        		                             
          32.1
        		                             
          increase in accounts payable
        		                            65 
          increase in related party payables
        		                            915 
          non cash financing activity
        		                             
          total assets
        		                             
          total equity
        		                            -27,376 
          net income per common share
        		                             
          net decrease in cash
        		                             
          cast at end of period
        		                             
          net cash financing activity
        		                             
          32.2
        		                             
          net cash used in
        		                             
          net cash provided by
        		                             
          adjustments to reconcile net income to net cash
        		                             
          used by operating activities:
        		                             
          investing activities
        		                             
          non cash financing activities:
        		                             
          a.